Document Detail


The glucose tolerance test, but not HbA(1c), remains the gold standard in identifying unrecognized diabetes mellitus and impaired glucose tolerance in hypertensive subjects.
MedLine Citation:
PMID:  16193196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The objective of this study was to compare the value of the oral glucose tolerance test (GTT), glycated hemoglobin concentration (HbA(1c)), and fasting plasma glucose (FPG) for identifying unrecognized diabetes mellitus (DM) and impaired glucose tolerance (IGT) in hypertensive subjects. One hundred forty-four consecutive subjects who were not known to have DM and who were attending the Hypertension Clinic underwent 24-hour ambulatory blood pressure (BP) monitoring. A GTT and an HbA(1c) measurement were also carried out. Abnormal results from GTT were found in 94 patients (65%). Results from FPG were not different between those with DM and IGT but were significantly higher than in the euglycemic subjects. The FPG was between 110-125 mg/dL (6.1-6.9 mmol/L) in 31% (n = 20) of patients with IGT and in 53% (n = 16) of those with DM. With use of the previously published criteria to diagnose DM of FPG > or = 103 mg/dL (5.7 mmol/L) and HbA(1c) > or = 5.9%, 33% of our diabetic subjects and 75% of those with IGT would have been misclassified as euglycemic. The previously reported cut-off point for HbA(1c) of >6.1% to diagnose DM was present in 77% of our patients with DM and in 14% (n = 9) of the patients with IGT. Multiple regression analysis showed that an abnormal result from GTT was independent of the level of clinical or ambulatory BP, nocturnal BP dip, cholesterol level, smoking history, race, or class of antihypertensive medication taken. FPG levels or HbA(1c), or their combination, are not accurate enough to identify DM or IGT in patients attending a hospital Hypertension Clinic. A GTT may be required in these patients to reliably identify those with DM or IGT.
Authors:
Abdul-Majeed Salmasi; Mark Dancy
Related Documents :
12925056 - Alveolar bone loss associated with glucose tolerance in japanese men.
9118766 - Fasting plasma glucose as a screening test for diabetes and its relationship with cardi...
19156626 - Metabolic syndrome and its single traits as risk factors for diabetes in people with im...
11353876 - Glucose intolerance is predicted by the high fasting insulin-to-glucose ratio.
10620096 - Insulin-mediated vasodilation and glucose uptake are independently related to fasting s...
24262796 - Cd73-dependent generation of adenosine and endothelial adora2b signaling attenuate diab...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Angiology     Volume:  56     ISSN:  0003-3197     ISO Abbreviation:  Angiology     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-09-29     Completed Date:  2005-11-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0203706     Medline TA:  Angiology     Country:  United States    
Other Details:
Languages:  eng     Pagination:  571-9     Citation Subset:  IM    
Affiliation:
Cardiac Research Unit, Cardiology Department, Central Middlesex Hospital, London, United Kingdom. majeed.salmasi@nwlh.nhs.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Antihypertensive Agents / therapeutic use
Diabetes Mellitus / diagnosis*
Female
Glucose Tolerance Test / standards*
Hemoglobin A, Glycosylated / analysis*
Humans
Hypertension / complications*
Male
Middle Aged
Regression Analysis
Sensitivity and Specificity
Chemical
Reg. No./Substance:
0/Antihypertensive Agents; 0/Hemoglobin A, Glycosylated

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The unilateral measurement of blood pressure may mask the diagnosis or delay the effective treatment...
Next Document:  Walnut consumption in hyperlipidemic patients.